PLX icon

Protalix BioTherapeutics

63 hedge funds and large institutions have $17.6M invested in Protalix BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
0%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
19
Reduced
4
Closed
30
Calls
$379K
Puts
$58K
Net Calls
+$321K
Net Calls Change
-$351K
Name Holding Trade Value Shares
Change
Shares
Change %
LP
76
LMR Partners
United Kingdom
-$126K -49,025 Closed
KAS
77
Kestra Advisory Services
Texas
-$114K -44,500 Closed
Prudential Financial
78
Prudential Financial
New Jersey
-$93.2K -36,400 Closed
Two Sigma Advisers
79
Two Sigma Advisers
New York
-$84.5K -33,015 Closed
Creative Planning
80
Creative Planning
Kansas
-$83.8K -32,740 Closed
CFM
81
Catalyst Funds Management
Australia
-$69.5K -27,139 Closed
HSBC Holdings
82
HSBC Holdings
United Kingdom
-$64.3K -25,535 Closed
CM
83
Capula Management
Cayman Islands
-$40.2K -15,690 Closed
Capstone Investment Advisors
84
Capstone Investment Advisors
New York
-$39.3K -15,336 Closed
Raymond James Financial
85
Raymond James Financial
Florida
-$38.8K -15,174 Closed
NA
86
NewEdge Advisors
Louisiana
-$38.6K -15,080 Closed
BHCM
87
Brevan Howard Capital Management
Jersey
-$34.5K -13,474 Closed
Hudson Bay Capital Management
88
Hudson Bay Capital Management
Connecticut
-$30.7K -12,000 Closed
Acadian Asset Management
89
Acadian Asset Management
Massachusetts
-$24K -9,691 Closed
PD
90
Point72 (DIFC)
United Arab Emirates
-$14.4K -5,623 Closed
Citadel Advisors
91
Citadel Advisors
Florida
-$7.21K -2,818 Closed
Lazard Asset Management
92
Lazard Asset Management
New York
-$2K -797 Closed